Dr. Lal Path Labs Ltd. — Others, 23-10-2024: Cessation

Dr. Lal PathLabs' Board approved its Q2 2024 financial results and declared a second interim dividend of INR 6 per share. CEO Dr. Om Prakash Manchanda will step down on March 31, 2025, after 19 years, but will continue as an advisor. The company reported an increase in revenue, with profits for the quarter at INR 1,308 million. The financial results include un-audited figures with a Limited Review Report from statutory auditors.